Metastatic melanoma gap analysis
Castellano K, Mirabi S, Ross SA, Penner N, Chambers A, Severn M, Haynes AE
Record ID 32018002214
English
Details
Project Status:
Completed
URL for project:
https://cadth.ca/metastatic-melanoma-gap-analysis
URL for protocol:
https://cadth.ca/sites/default/files/pdf/HE0004_Metastatic_Melanoma_Gap_Analysis_Protocol.pdf
Year Published:
2018
URL for published report:
https://cadth.ca/sites/default/files/pdf/HE0004_Metastatic_Melanoma_Gap_Analysis_TR_Final.pdf
URL for additional information:
https://cadth.ca/metastatic-melanoma-gap-analysis
English language abstract:
An English language summary is available
Publication Type:
Rapid Review
Country:
Canada
MeSH Terms
- Melanoma
- Immunotherapy
- Immunotherapy, Adoptive
- Antineoplastic Combined Chemotherapy Protocols
- Antineoplastic Agents
Keywords
- Melanoma
- Immunotherapy
- Ipilimumab
- Pembrolizumab
- Nivolumab
- BRAF mutation targeted therapy
- Dabrafenib
- Trametinib
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
<p>Canadian Agency for Drugs and Technologies in Health (CADTH)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.